IGXT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IGXT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Intelgenx Technologies's share price for the quarter that ended in Dec. 2023 was $0.13813. Intelgenx Technologies's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 174.66 Mil. Therefore, Intelgenx Technologies's market cap for the quarter that ended in Dec. 2023 was $24.13 Mil.
Intelgenx Technologies's quarterly market cap declined from Jun. 2023 ($33.19 Mil) to Sep. 2023 ($24.61 Mil) and declined from Sep. 2023 ($24.61 Mil) to Dec. 2023 ($24.13 Mil).
Intelgenx Technologies's annual market cap declined from Dec. 2021 ($55.10 Mil) to Dec. 2022 ($34.46 Mil) and declined from Dec. 2022 ($34.46 Mil) to Dec. 2023 ($24.13 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Intelgenx Technologies's Enterprise Value for Today is $41.86 Mil.
The historical data trend for Intelgenx Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelgenx Technologies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Market Cap | Get a 7-Day Free Trial | 44.15 | 24.51 | 55.10 | 34.46 | 24.13 |
Intelgenx Technologies Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Market Cap | Get a 7-Day Free Trial | 34.46 | 31.44 | 33.19 | 24.61 | 24.13 |
For the Biotechnology subindustry, Intelgenx Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Intelgenx Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Intelgenx Technologies's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
Market Cap (A: Dec. 2023 ) | = | Share Price (A: Dec. 2023 ) | * | Shares Outstanding (EOP) (A: Dec. 2023 ) |
= | $0.13813 | * | 174.658 | |
= | $24.13 |
Intelgenx Technologies's Market Cap for the quarter that ended in Dec. 2023 is calculated as
Market Cap (Q: Dec. 2023 ) | = | Share Price (Q: Dec. 2023 ) | * | Shares Outstanding (EOP) (Q: Dec. 2023 ) |
= | $0.13813 | * | 174.658 | |
= | $24.13 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelgenx Technologies (OTCPK:IGXT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Thank you for viewing the detailed overview of Intelgenx Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Atai Life Sciences Ag | 10 percent owner | KRAUSENSTRASSE 9-10, BERLIN 2M 10117 |
Atai Life Sciences N.v. | 10 percent owner | 524 BROADWAY, NEW YORK NY 10013 |
Karen Kalayajian | officer: VP, Finance&Admin - Subsidiary | 4896 RUE EDOUARD-BRUNETTE, LAVAL A8 H7T 0J4 |
Dwight Gorham | officer: CEO | 15B BARKLEY ST, ARNPRIOR A6 K7S 3G8 |
David Kideckel | officer: SVP, Corp. Dev&SA - Subsidiary | 23 PEVERIL HILL SOUTH, TORONTO, ON A6 M6C 3A7 |
Horst G Zerbe | 10 percent owner, officer: Chief Executive Officer | 714 MAIN ROAD, HUDSON A8 JOP1H0 |
Andre Godin | officer: CFO | 440 DES CARMANTINES, LAVAL A8 H7X 0B6 |
Tommy Kenny | officer: VP IP,Lgl Affairs - Subsidiary | 88 CH. DES SAULES, ST-ADOLPHE D' HOWARD A8 J0T 2B0 |
Dana Matzen | officer: VP Business+Corp. Development | 4771 RUE SHERBROOKE O., WESTMOUNT A8 H3Z1G5 |
Ingrid Zerbe | 10 percent owner, officer: Corporate Secretary | 714 MAIN ROAD, HUDSON A8 J0P1H0 |
Rodolphe Obeid | officer: Vice President, Operations | 4779 RUE VILLERET, PIERREFOND A8 H9K1P6 |
Bernard Boudreau | director | 2 TURNMILL DR., HALIFAX A5 B3M4H2 |
John Edward Durham | officer: Vice President Manufacturing | 102 MAYFAIR, HUDSON A8 J0P1H0 |
Mark Nawacki | director | 118 ARLINGTON AVENUE, WESTMOUNT A8 H3Y2W4 |
Robert J. Bechard | officer: VP Corporate Development | 141 EASTON AVENUE, MONTREAL WEST A8 H4X 1L4 |
From GuruFocus
By sperokesalga sperokesalga • 05-11-2023
By Stock market mentor Stock market mentor • 01-09-2023
By Marketwired • 09-19-2023
By Marketwired • 07-25-2023
By Marketwired • 11-06-2023
By Marketwired • 08-01-2023
By Marketwired • 08-10-2023
By Stock market mentor Stock market mentor • 01-23-2023
By sperokesalga sperokesalga • 03-29-2023
By GlobeNewswire • 07-21-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.